Stockfacts
Explore
Use Cases
Docs
Pricing
English
Log in
Sign up free
Overview
Financials
Trends
Transcripts
Options
Shorts
Institutions
Insiders
Corporate Actions
SEC Filings
RGNX
REGENXBIO Inc.
CIK 0001590877 · Nasdaq
Nasdaq
Health Care
Biological Products, (No Diagnostic Substances)
$10.72
↓ 0.34 (-3.07%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read:
Neutral
Overall score · based on 4/4 lenses
Fundamentals
Ownership
Technicals
Options
Bullish: Ownership; Risks: Options
Key stats
Market Cap
$707.66M
P/E Ratio
-3.60
EPS
-3.76
Dividend Yield
Not covered
52W Position
49%
Beta
1.99
Valuation multiples
Fwd P/E
Not covered
PEG
0.26
P/B
9.86
P/S
4.06
EV/Revenue
3.85
ROE
-273.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).
Price · 1Y
250 trading days
End-of-day close, not real-time intraday
52-Week Range
Position 49%
$5.46
$16.19
Latest Financials
2025-12-31 FY
Revenue
$170.44M
Net Income
-$193.88M
Total Assets
$453.03M
Free Cash Flow
-$126.38M
Recent news